More Than 15 Percent of Providers Depart BPCI Advanced
One in seven providers in the largest Medicare bundled payment model left after five months, new data reveal. But that may be good news for the program.
Why More than 15 Percent of Providers Are Departing BPCI-Advanced
Read why more than 15 percent of BPCI-Advanced providers are departing the program.
Interoperability and Patient Access to Health Data Proposed Rule Summary
This document summarizes the proposed rule on interoperability and patient access to health data, published by CMS, in the March 4, 2019, Federal Register.
HFMA Offers Recommendations to Senate to Reduce Total Cost of Care while Improving Patient Outcomes
This letter contains HFMA's recommendations to the Senate HELP committee on ways to reduce the total cost of care while improving patient outcomes.
Community Benefit & Transparency Tools
HFMA has compiled these resources for hospitals and health systems to use for compliance when listing standard charges to the public and procedures around charity care.
HFMA’s Payment Reform Project White Papers
HFMA has led a payment reform thought leadership initiative to identify the principles that should guide changes to the current healthcare payment system and the competencies that providers will need to succeed. The initiative's findings and recommendations are summarized in these white papers.
Q&A: Do Price Transparency Regulations Improve the Patient Experience?
Two healthcare finance leaders explain why their organizations are placing more emphasis on patient education and customer service than on new regulations surrounding charge transparency.
Provider Nimbleness Required for Diverse Value-Based Healthcare Models
Providers must be nimble to adapt to new value-based healthcare strategies.
National Hospital Survey Shares Insight into CMS’s Price Transparency Requirement
Hospitals expressed uncertainty about the usefulness of information supplied in response to CMS’s IPPS transparency requirements, but also recognize that the rule amplifies healthcare industry efforts to provide meaningful price estimates for healthcare services.
340B Ruling: Good News for Some, Maybe
340B-eligible facilities are unsure of the fate of the 340B discount drug program as they await a U.S. District Court ruling on remedies that could further alter payments.